The surgical robotic systems market is witnessing significant growth, driven by the rising adoption of minimally invasive procedures and the increasing demand for precision and improved surgical outcomes. Technological advancements in robotic platforms, including enhanced imaging, AI integration, and improved instrument dexterity, are further accelerating market expansion. 

LAS VEGAS, March 10, 2026 /PRNewswire/ -- DelveInsight's Surgical Robotic Systems Market Insights report provides the current and forecast market analysis, individual leading surgical robotic systems companies' market shares, challenges, surgical robotic systems market drivers, barriers, trends, and key surgical robotic systems companies in the market.

Surgical Robotic Systems Market Summary

• 2025 Surgical Robotic Systems Market Size: ~USD 11 Billion
• 2034 Projected Surgical Robotic Systems Market Size: ~USD 30 Billion
• Surgical Robotic Systems Market Growth Rate (2026-2034): ~13% 
• Largest Surgical Robotic Systems Market: North America
• Largest Component Segment: System Category
• Key Companies in the Surgical Robotic Systems Market: Intuitive Surgical Inc., Stryker, Johnson & Johnson Services, Inc., Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp., Asensus Surgical US, Inc., Globus Medical, Microport Scientific Corporation, Smith & Nephew plc., Accuray Incorporated, THINK Surgical, Renishaw plc., Zimmer Biomet, Siemens Healthineers, Preceyes BV, MicroSure, Memic Innovative Surgery Ltd., and others

To read more about the latest highlights related to the surgical robotic systems market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/surgical-robotic-system-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=scpr

Key Factors Contributing to the Rise in Growth of the Surgical Robotic Systems Market

• Rising Demand for Minimally Invasive Surgeries: One of the most significant drivers is the growing preference for minimally invasive surgical procedures (MIS). These procedures involve smaller incisions, reduced blood loss, shorter hospital stays, and faster patient recovery compared to traditional open surgeries.
• Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and orthopedic disorders is increasing the number of surgical interventions globally.
• Rapid Technological Advancements in Robotics: Continuous advancements in robotics technology, such as artificial intelligence (AI), machine learning, high-definition 3D visualization, and real-time imaging systems, have significantly improved the capabilities of robotic surgical platforms.
• Improved Surgical Precision and Reduced Complications: Robotic-assisted systems provide superior dexterity, tremor filtration, and enhanced visualization, allowing surgeons to perform delicate procedures with greater accuracy.
• Growing Aging Population: The global rise in the elderly population has led to an increased prevalence of age-related diseases requiring surgical treatment.
• Expansion of Robotic Surgery in Hospitals and Ambulatory Surgical Centers: Healthcare facilities, including ambulatory surgical centers (ASCs), are increasingly adopting robotic systems to improve surgical efficiency and reduce patient recovery times.
• Increasing Investments and Healthcare Infrastructure Development: Significant investments by governments, healthcare institutions, and medical device companies in robotic technologies and surgical innovation are accelerating market growth.

Regional Surgical Robotic Systems Market Insights

North America

• North America holds the dominant share of the surgical robotic systems market, primarily due to early adoption of robotic-assisted surgery, well-established healthcare infrastructure, and significant investment in medical technology innovation. 
• The United States represents the largest market within the region, supported by a high number of robotic-assisted procedures, strong reimbursement frameworks, and the presence of major industry players. 
• Hospitals across the region increasingly integrate robotic platforms into specialties such as urology, gynecology, orthopedics, and general surgery, further strengthening market growth.

Europe

• Europe represents the second-largest regional market, supported by increasing adoption of minimally invasive surgical techniques and growing healthcare expenditure. 
• Countries such as Germany, the United Kingdom, France, and Italy are key contributors, driven by the expansion of robotic surgery programs in tertiary hospitals and academic medical centers. 
• Regulatory support, expanding surgeon training programs, and increasing patient preference for precision-based surgical procedures are also supporting the adoption of robotic surgical systems across the region.

Asia-Pacific

• The Asia-Pacific region is expected to witness the fastest growth in the surgical robotic systems market. Rapid healthcare infrastructure development, rising medical tourism, and increasing awareness of advanced surgical technologies are key drivers. 
• Countries such as China, Japan, South Korea, and India are investing heavily in hospital modernization and digital health technologies. 
• In addition, the growing burden of chronic diseases and increasing demand for minimally invasive surgeries are accelerating the adoption of robotic-assisted surgical platforms in the region.

Latin America

• Latin America is experiencing gradual market expansion, supported by improving healthcare access and growing investment in private hospital infrastructure. 
• Brazil and Mexico represent the major markets within the region, where large hospitals are increasingly adopting robotic surgical technologies to enhance surgical precision and patient outcomes.

Middle East and Africa

• The Middle East and Africa region currently accounts for a smaller share of the global surgical robotic systems market; however, adoption is steadily increasing. 
• Countries such as the United Arab Emirates, Saudi Arabia, and South Africa are investing in advanced healthcare technologies as part of broader healthcare modernization initiatives. 
• The expansion of specialty hospitals and the increasing focus on medical tourism are expected to drive future market growth in this region.

Get a sneak peek at the surgical robotic systems market dynamics @ Surgical Robotic Systems Market Trends

Recent Developmental Activities in the Surgical Robotic Systems Market

• In March 2026, Golden Valley Memorial Healthcare marked a major step forward in orthopedic innovation after successfully conducting the world's first knee replacement procedure with a compact robotic surgical system offering broader implant compatibility.
• In February 2026, THINK Surgical, Inc., an innovator in orthopedic surgical robotics, announced that the first cases had been completed using the TMINI Miniature Robotic System in combination with the Triathlon Knee System from Stryker.
• In February 2026, Medtronic announced that the first commercial surgical procedure in the United States using its recently FDA-cleared Hugo™ robotic-assisted surgery (RAS) system had been completed. The operation was performed by Jihad Kaouk, MD, Professor and Chair of the Glickman Urologic Institute and the Zegarac-Pollock Endowed Chair in Robotic Surgery at the Cleveland Clinic.
• In December 2025, CMR Surgical announced that its second-generation surgical robotic system, the Versius Plus surgical robot, had secured FDA 510(k) clearance.
• In December 2025, SS Innovations International, Inc. announced that it submitted a 510(k) premarket notification to the FDA on December 5, 2025, seeking clearance for its SSi Mantra Surgical Robotic System to be used across multiple surgical specialties, including general, urological, colorectal, gynecological, and cardiac procedures.
• In December 2025, Medtronic announced that the FDA had granted clearance for the Hugo™ robotic-assisted surgery (RAS) system for urologic surgical procedures in the United States. The approval introduces a flexible robotic platform that enables surgeons and healthcare systems to broaden their soft-tissue robotic surgery capabilities and improve access to minimally invasive treatments.
• In November 2025, XCath announced the successful first-in-human use of its EVR robotic system to treat three patients with complex brain aneurysms.
• In November 2025, IMPLANET announced a new partnership agreement with 8i Robotics Inc.
• In November 2025, Sovato completed a Series B funding round to expand and advance its remote robotic surgery (telesurgery) platform.
• In October 2025, Edge Medical announced that its robotic-assisted "super system," MSP2000, had been granted CE mark approval.

What are Surgical Robotic Systems?

Surgical robotic systems are advanced medical technologies designed to assist surgeons in performing complex procedures with enhanced precision, flexibility, and control. These systems typically consist of a robotic console operated by the surgeon, robotic arms equipped with specialized surgical instruments, and a high-definition 3D visualization system that provides a magnified view of the surgical site. Rather than acting autonomously, the robot translates the surgeon's hand movements into smaller, highly precise movements of the instruments inside the patient's body. Surgical robotic systems are widely used in minimally invasive procedures across specialties such as urology, gynecology, cardiology, and oncology, helping to reduce surgical trauma, improve accuracy, and shorten patient recovery time compared with conventional open or laparoscopic surgeries. Their adoption is increasing globally as hospitals seek to improve surgical outcomes, enhance surgeon ergonomics, and support the growing demand for minimally invasive interventions.

Surgical Robotic Systems Market Assessment

• Surgical Robotic Systems Market Segmentation
  • Surgical Robotic Systems Market Segmentation By Component: System, Instruments & Accessories, and Services
  • Surgical Robotic Systems Market Segmentation By Application: System, Instruments & Accessories, and Services
  • Surgical Robotic Systems Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
  • Surgical Robotic Systems Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the surgical robotic systems market are set to emerge as the trendsetter explore @ Surgical Robotic Systems Market Analysis

Table of Contents 

Interested in knowing the Surgical Robotic Systems market share by 2034? Click to get a snapshot of the Surgical Robotic Systems Market Size 

Related Reports

Minimally Invasive Surgical Devices Market

Minimally Invasive Surgical Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key minimally invasive surgical devices companies, including Abbott, Olympus, Intuitive Surgical Inc., Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, Boston Scientific Corporation, CONMED Corporation, KARL STORZ GmbH, CooperSurgical, Inc., Cook, AngioDynamics, FUJIFILM Corporation, Symmetry Surgical Inc., B. Braun Melsungen AG, BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Zimmer Biomet, Richard Wolf GmbH, Microport Scientific Corporation, and others.

Robotic Process Automation (RPA) in Healthcare Market

Robotic Process Automation (RPA) in Healthcare Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key RPA in healthcare companies, including UiPath, Automation Anywhere, Blue Prism, Microsoft (Power Automate), AutomationEdge, Kofax (Tungsten Automation), Pegasystems, and others.

Ambulatory Surgical Centers Market

Ambulatory Surgical Centers Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key ambulatory surgical centers companies, including AMSURG, Surgical Care Affiliates, HCA Healthcare, Tenet Healthcare, Surgery Partners, Cerner Corporation, United Surgical Partners International, Hunterdon Healthcare, Surg Center Gilbert, Beaumont Health, Ambulatory Surgical Centers of America, Center for Health Ambulatory Surgery Centers, TeamHealth, Pediatrix Medical Group, Quoram Health Corporation, and others.

AI in Diagnostics Market

AI in Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in diagnostics companies, including Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us

Shruti Thakur

info@delveinsight.com

+14699457679 

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/global-surgical-robotic-systems-market-is-set-to-reach-usd-30-billion-by-2034-due-to-the-rising-demand-for-precision-surgery--delveinsight-302709045.html

Zalando hat für das Geschäftsjahr 2025 deutlich verbesserte Kennzahlen vorgelegt und setzt zugleich ein starkes Signal an den Kapitalmarkt: Der Berliner Online-Modehändler steigerte den Konzernumsatz um 16,8 % auf 12,3 Milliarden Euro, das bereinigte EBIT legte um 15,6 % auf 591 Millionen Euro zu. Der Kurs reagierte spürbar: Nach der Zahlenvorlage legte die im DAX notierte Aktie kräftig zu und machte einen Teil der vorangegangenen Verluste wett. Auf Wochensicht verteuerte sich das Papier um rund 12 %, auf Monatssicht ergibt sich ein Plus im niedrigen einstelligen Prozentbereich, auch wenn die Bilanz seit Jahresbeginn weiterhin negativ bleibt.

Getrieben wird die Entwicklung vor allem durch Zalandos strategischen Fokus auf Daten und Künstliche Intelligenz. Das Unternehmen nutzt KI über die gesamte Daten- und Infrastrukturplattform hinweg und positioniert sich als Vorreiter für die nächste Generation des sogenannten agentic commerce in Europa. Im B2C-Geschäft zahlt sich insbesondere der Multi-App-Ansatz aus: Das Bruttowarenvolumen stieg auf 17,6 Milliarden Euro, das bereinigte EBIT in diesem Segment kletterte auf 536 Millionen Euro. Die Zahl der aktiven Kundinnen und Kunden erreichte mit 62 Millionen einen neuen Rekordwert, was auf eine weiter steigende Reichweite der Plattform hindeutet.

Auch im B2B-Bereich läuft das Geschäft deutlich besser. Zalando meldet einen Umsatzanstieg um 14,6 % auf 1,1 Milliarden Euro, das bereinigte EBIT hat sich mehr als verdoppelt. Die Softwareeinheit SCAYLE expandiert in die USA und konnte dort einen bedeutenden Auftrag für das globale Direktvertriebsgeschäft von Levi's® gewinnen. Zusätzlichen Rückenwind verspricht sich der Konzern von der Integration des übernommenen Modehändlers ABOUT YOU: Die ursprünglich bis 2029 erwarteten jährlichen Synergien von 100 Millionen Euro sollen nun bereits 2028 realisiert werden. Für 2026 stellt das Management eine weitere Beschleunigung und anhaltend profitables Wachstum in Aussicht und sieht das Unternehmen damit auf Kurs zu seinen mittelfristigen Zielen bis 2028.

Vor diesem Hintergrund kündigte Zalando ein Aktienrückkaufprogramm im Volumen von bis zu 300 Millionen Euro an. Damit will der Konzern überschüssiges Kapital an die Anteilseigner zurückführen und unterstreicht zugleich sein Vertrauen in die eigene Fähigkeit zur Margenausweitung und nachhaltigen Cash-Generierung. An der Börse kam die Ankündigung gut an: Die Marktkapitalisierung liegt bei rund 5,7 Milliarden Euro, basierend auf etwa 264 Millionen ausstehenden Aktien. Analysten und Anleger beobachten nun, inwieweit die Kombination aus KI-Investitionen, internationalem Ausbau des B2B-Geschäfts und konsequenter Kapitalallokation die bisherige Kursvolatilität reduzieren und den Wert des Unternehmens langfristig stützen kann.

Überschattet werden die starken Zahlen jedoch von der Entscheidung, das große Logistikzentrum in Erfurt zum Ende September zu schließen. Der Thüringer Standort, der seit Jahren ein wichtiger Baustein im europäischen Logistiknetzwerk von Zalando war, steht damit vor dem Aus. Die Schließung sorgt regional für Kritik und wirft Fragen nach den sozialen und strukturellen Folgen für Beschäftigte und Standort auf. Für Zalando ist der Schritt Teil einer umfassenden Neuaufstellung der operativen Infrastruktur, bei der Effizienzgewinne und die zunehmende Automatisierung im Logistikbereich eine zentrale Rolle spielen dürften. Wie sich der Umbau konkret auf Kostenstruktur, Servicequalität und öffentliche Wahrnehmung auswirkt, bleibt eine der zentralen Fragen für die kommenden Jahre.